About VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA
Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs.
👉vitadao.com
The Mouse Longevity Chronicles: Unraveling Aging with Dr. Richard Miller during The Aging Science podcast by VitaDAO
In this podcast, I (@aging_scientist) spoke with Dr. Rich Miller about the ins and outs of mouse aging.
The topics we discussed, roughly in this order, included the Interventions Testing Program, rapamycin, mecilizine, and other lifespan-extending drugs. We talked about the importance of genetically heterogenous mouse stocks and the issues with fast-aging progeroid mouse models. We also covered his more recent work on aging rate indicators and the difference between classic biomarkers and aging rate indicators. Finally, we talked about the importance of lifespan research, misuse of the word healthspan, and the emerging use of frailty indices in mice.
VitaDAO and Kamil Pabis, MSc (the @Aging_Scientist on Twitter) bring this podcast to you.
2 Mar 2023
Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO
Slowing aging by a couple of percents would save more money than curing any single disease, be it cancer, heart disease, or diabetes. Aging is, in fact, the major risk factor that all these diseases have in common. For this reason, slowing aging becomes the most efficient path to a sustainable and healthy future for humanity.
To get this message out we started The Aging Science podcast. We will bring you interviews and frank conversations with leading experts in the field of longevity, as well as evidence-based health advice to support you on this journey.
This podcast is brought to you by VitaDAO and Kamil Pabis, MSc (the @Aging_Scientist on Twitter).
In this podcast, I (@aging_scientist) had the pleasure of interviewing Asst. Prof Alaattin Kaya (@akay_lab).
We talked about recent breakthroughs in the field, the difficulties of getting funding for risky and novel research, funding agencies, “fishing expeditions”, the importance of overexpression genetic screens in aging research, novel mechanisms of action, and the replication crisis.
23 Feb 2023
Insights on Grant-making and Systemic Change: Lessons from Impetus and Beyond
Insights on Grant-making and Systemic Change: Lessons from Impetus and Beyond with Martin Borch Jensen & Lada Nuzhna.
Outline:
0:00 What is Impetus and how did it get started?
3:12 Takeaways from running and creating Impetus Grants
5:04 Playbook for starting a grant-making program.
12:29 Common misunderstandings between the private sector and academia about funding.
14:12 The role of academia in publishing negative results
23:18 The most impactful levers for systemic change.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Contact VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
